Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | mitogen-activated protein kinase 14 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trypanosoma brucei | mitogen-activated protein kinase 5 | mitogen-activated protein kinase 14 | 360 aa | 336 aa | 33.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | aminopeptidase | 0.0156 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | Xaa-Pro aminopeptidase | 0.0156 | 0 | 0.5 |
Mycobacterium ulcerans | methionine aminopeptidase | 0.0156 | 0 | 0.5 |
Chlamydia trachomatis | methionine aminopeptidase | 0.0156 | 0 | 0.5 |
Trichomonas vaginalis | Clan MG, familly M24, aminopeptidase P-like metallopeptidase | 0.1257 | 1 | 1 |
Mycobacterium ulcerans | dipeptidase PepE | 0.0156 | 0 | 0.5 |
Onchocerca volvulus | Methionine aminopeptidase 2 homolog | 0.1257 | 1 | 1 |
Mycobacterium tuberculosis | Probable cytoplasmic peptidase PepQ | 0.0156 | 0 | 0.5 |
Mycobacterium leprae | Probable cytoplasmic peptidase PepQ | 0.0156 | 0 | 0.5 |
Loa Loa (eye worm) | initiation factor 2-associated protein | 0.1257 | 1 | 1 |
Leishmania major | methionine aminopeptidase 2, putative | 0.1257 | 1 | 1 |
Trichomonas vaginalis | Clan MG, familly M24, aminopeptidase P-like metallopeptidase | 0.1257 | 1 | 1 |
Trypanosoma cruzi | metallo-peptidase, Clan MG, Family M24 | 0.1257 | 1 | 1 |
Trypanosoma cruzi | metallo-peptidase, Clan MG, Family M24 | 0.1257 | 1 | 1 |
Mycobacterium tuberculosis | Dipeptidase PepE | 0.0156 | 0 | 0.5 |
Mycobacterium leprae | PROBABLE METHIONINE AMINOPEPTIDASE MAPB (MAP) (PEPTIDASE M) | 0.0156 | 0 | 0.5 |
Echinococcus granulosus | methionyl aminopeptidase 2 | 0.1257 | 1 | 1 |
Mycobacterium tuberculosis | Methionine aminopeptidase MapA (map) (peptidase M) (MetAP) | 0.0156 | 0 | 0.5 |
Toxoplasma gondii | methionine aminopeptidase 2, putative | 0.1257 | 1 | 1 |
Plasmodium vivax | methionine aminopeptidase 2, putative | 0.1257 | 1 | 1 |
Mycobacterium ulcerans | methionine aminopeptidase MapB | 0.0156 | 0 | 0.5 |
Mycobacterium leprae | PROBABLE METHIONINE AMINOPEPTIDASE MAPA (MAP) (PEPTIDASE M) (MetAP) | 0.0156 | 0 | 0.5 |
Trichomonas vaginalis | Clan MG, familly M24, aminopeptidase P-like metallopeptidase | 0.1257 | 1 | 1 |
Mycobacterium ulcerans | cytoplasmic peptidase PepQ | 0.0156 | 0 | 0.5 |
Mycobacterium ulcerans | dipeptidase | 0.0156 | 0 | 0.5 |
Treponema pallidum | methionine aminopeptidase (map) | 0.0156 | 0 | 0.5 |
Entamoeba histolytica | methionine aminopeptidase, putative | 0.1257 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | methionine aminopeptidase | 0.0156 | 0 | 0.5 |
Trypanosoma brucei | metallo-peptidase, Clan MG, Family M24 | 0.1257 | 1 | 1 |
Giardia lamblia | Methionine aminopeptidase | 0.1257 | 1 | 1 |
Schistosoma mansoni | methionyl aminopeptidase 2 (M24 family) | 0.1257 | 1 | 1 |
Trichomonas vaginalis | Clan MG, familly M24, aminopeptidase P-like metallopeptidase | 0.1257 | 1 | 1 |
Mycobacterium tuberculosis | Methionine aminopeptidase MapB (map) (peptidase M) | 0.0156 | 0 | 0.5 |
Treponema pallidum | aminopeptidase P | 0.0156 | 0 | 0.5 |
Echinococcus multilocularis | methionyl aminopeptidase 2 | 0.1257 | 1 | 1 |
Trypanosoma brucei | methionine aminopeptidase 2, putative | 0.1257 | 1 | 1 |
Chlamydia trachomatis | aminopeptidase P | 0.0156 | 0 | 0.5 |
Plasmodium falciparum | methionine aminopeptidase 2 | 0.1257 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 1.79 uM | Inhibition of p38a MAPK (unknown origin) by radiometric assay | ChEMBL. | 24508134 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.